Clinicopathological and prognostic significance of mucin phenotype in gastric cancer

Journal of Surgical Oncology

Volumn 98, Issue 2, 2008, Pages 124-129

  Wakatsuki, Kohei ^a   Yamada, Yukishige ^a   Narikiyo, Michihiro ^a   Ueno, Masato ^a   Takayama, Tomoyoshi ^a   Tamaki, Hidetoshi ^a   Miki, Katsuhiko ^a   Matsumoto, Sohei ^a   Enomoto, Koji ^a   Yokotani, Tomoyo ^a   Nakajima, Yoshiyuki ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Gastric cancer; Mucin phenotype; Prognosis; RUNX3; Tumor suppressor gene

Indexed keywords

COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; MUCIN; MUCIN 2; MUCIN 5AC; MUCIN 6; TRANSCRIPTION FACTOR RUNX3;

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER SURVIVAL; FEMALE; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; STOMACH CARCINOMA; TREATMENT OUTCOME; TUMOR SUPPRESSOR GENE;

CARCINOMA; CORE BINDING FACTOR ALPHA 3 SUBUNIT; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MUCINS; NEPRILYSIN; PHENOTYPE; PROGNOSIS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 49149123885     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21093     Document Type: Article

References (33)

1. Lauren P: The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965;64:31-49.
2. Nakamura K, Sugano H, Takagi K: Carcinoma of the stomach in incipient phase: Its histogenesis and histological appearances. Gann 1968;59:251-258.
3. Saito K, Shimoda T: The histogenesis and early invasion of gastric cancer. Acta Pathol Jpn 1986;36:1307-1318.
4. Tahara E: Genetic alterations in human gastrointestinal cancers. The application to molecular diagnosis. Cancer 1995;75:1410-1417.
5. Egashira Y, Shimoda T, Ikegami M: Mucin histochemical analysis of minute gastric differentiated adenocarcinoma. Pathol Int 1999;49:55-61.
6. Sasaki I, Yao T, Nawata H, et al.: Minute gastric carcinoma of differentiated type with special reference to the significance of intestinal metaplasia, proliferative zone, and p53 protein during tumor development. Cancer 1999;85:1719-1729.
7. Endoh Y, Tamura G, Motoyama T, et al.: Well-differentiated adenocarcinoma mimicking complete-type intestinal metaplasia in the stomach. Hum Pathol 1999;30:826-832.
8. Machado JC, Nogueira AM, Carneiro F, et al.: Gastric carcinoma exhibits distinct types of cell differentiation: An immunohistochemical study of trefoil peptides (TFF1 and TFF2) and mucins (MUC1, MUC2, MUC5AC, and MUC6). J Pathol 2000;190:437-443.
9. Koseki K, Takizawa T, Koike M, et al.: Distinction of differentiated type early gastric carcinoma with gastric type mucin expression. Cancer 2000;89:724-732.
10. Tatematsu M, Ichinose M, Miki K, et al.: Gastric and intestinal phenotypic expression of human stomach cancers as revealed by pepsinogen immunohistochemistry and mucin histochemistry. Acta Pathol Jpn 1990;40:494-504.
11. Yamachika T, Inada K, Fujimitsu Y, et al.: Intestinalization of gastric signet ring cell carcinomas with progression. Virchows Arch 1997;431:103-110.
12. Yoshikawa A, Inada Ki K, Yamachika T, et al.: Phenotypic shift in human differentiated gastric cancers from gastric to intestinal epithelial cell type during disease progression. Gastric Cancer 1998;1:134-141.
13. Tsukashita S, Kushima R, Bamba M, et al.: MUC gene expression and histogenesis of adenocarcinoma of the stomach. Int J Cancer 2001;94:166-170.
14. Saito A, Shimoda T, Nakanishi Y, et al.: Histologic heterogeneity and mucin phenotypic expression in early gastric cancer. Pathol Int 2001;51:165-171.
15. Kabashima A, Yao T, Sugimachi K, et al.: Relationship between biologic behavior and phenotypic expression in intramucosal gastric carcinomas. Hum Pathol 2002;33:80-86.
16. Shibata N, Watari J, Fujiya M, et al.: Cell kinetics and genetic instabilities in differentiated type early gastric cancers with different mucin phenotype. Hum Pathol 2003;34:32-40.
17. Tajima Y, Yamazaki K, Nishino N, et al.: Gastric and intestinal phenotypic marker expression in gastric carcinomas and recurrence pattern after surgery-immunohistochemical analysis of 213 lesions. Br J Cancer 2004;91:1342-1348.
18. Kim YS, Gum J, Jr., Brockhausen I: Mucin glycoproteins in neoplasia. Glycoconj J 1996;13:693-707.
19. Tajima Y, Shimoda T, Nakanishi Y, et al.: Gastric and intestinal phenotypic marker expression in gastric carcinomas and its prognostic significance: Immunohistochemical analysis of 136 lesions. Oncology 2001;61:212-220.
20. Osaki M, Moriyama M, Adachi K, et al.: Expression of RUNX3 protein in human gastric mucosa, intestinal metaplasia and carcinoma. Eur J Clin Invest 2004;34:605-612.
21. Li QL, Ito K, Sakakura C, et al.: Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 2002;109:113-124.
22. Wei D, Gong W, Oh SC, et al.: Loss of RUNX3 expression significantly affects the clinical outcome of gastric cancer patients and its restoration causes drastic suppression of tumor growth and metastasis. Cancer Res 2005;65:4809-4816.
23. Japanese Gastric Cancer Association: Japanese Classification of Gastric Carcinoma - 2nd English Edition. Gastric Cancer 1998;1:10-24.
24. Sobin L, Wittekind C: International Union Cancer (UICC): TNM classification of malignant tumors, 6th edition. New York: Wiley-Liss; 2002.
25. Reis CA, David L, Correa P, et al.: Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res 1999;59:1003-1007.
26. Tytgat KM, Buller HA, Opdam FJ, et al.: Biosynthesis of human colonic mucin: Muc2 is the prominent secretory mucin. Gastroenterology 1994;107:1352-1363.
27. Ajioka Y, Watanabe H, Jass JR: MUC1 and MUC2 mucins in flat and polypoid colorectal adenomas. J Clin Pathol 1997;50:417-421.
28. Sato Y, Itoh F, Hinoda Y, et al.: Expression of CD10/neutral endopeptidase in normal and malignant tissues of the human stomach and colon. J Gastroenterol 1996;31:12-17.
29. Guilford P, Hopkins J, Harraway J, et al.: E-cadherin germline mutations in familial gastric cancer. Nature 1998;392:402-405.
30. Tamura G, Kihana T, Nomura K, et al.: Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis. Cancer Res 1991;51:3056-3058.
31. Park K, Kim SJ, Bang YJ, et al.: Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: Correlation with sensitivity to growth inhibition by TGF-beta. Proc Natl Acad Sci USA 1994;91:8772-8776.
32. Fukushige S, Matsubara K, Yoshida M, et al.: Localization of a novel v-erbB-related gene, c-erbB-2, on human chromosome 17 and its amplification in a gastric cancer cell line. Mol Cell Biol 1986;6:955-958.
33. Rege-Cambrin G, Scaravaglio P, Carozzi F, et al.: Karyotypic analysis of gastric carcinoma cell lines carrying an amplified c-met oncogene. Cancer Genet Cytogenet 1992;64:170-173.